Onward Medical N.V.
EBR:ONWD.BR
4.71 (EUR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| -0.198 | -0.214 | 0.464 | 0.464 | 0.593 | 0.593 | 0.482 | 0.482 | 0.407 | 0.407 | 0.293 | 0.293 | 0.295 | 0.295 | 0.106 | 0.106 |
| Cost of Revenue
| 0.397 | 13.706 | 0.329 | 4.294 | 0.392 | 3.892 | 0.343 | 3.452 | 3.672 | 3.672 | 2.318 | 2.318 | 2.166 | 2.166 | 1.901 | 1.901 |
| Gross Profit
| -0.595 | -13.92 | 0.135 | -3.83 | 0.201 | -3.299 | 0.139 | -2.971 | -3.266 | -3.266 | -2.025 | -2.025 | -1.871 | -1.871 | -1.795 | -1.795 |
| Gross Profit Ratio
| 3.005 | 65.047 | 0.291 | -8.254 | 0.338 | -5.568 | 0.288 | -6.169 | -8.033 | -8.033 | -6.91 | -6.91 | -6.353 | -6.353 | -17.014 | -17.014 |
| Reseach & Development Expenses
| 6.203 | 3.819 | 7.638 | 3.819 | 6.923 | 3.462 | 6.215 | 3.108 | 3.385 | 3.385 | 1.925 | 1.925 | 1.51 | 1.51 | 1.402 | 1.402 |
| General & Administrative Expenses
| 2.376 | 3.288 | 3.288 | 3.288 | 2.884 | 2.884 | 2.398 | 2.398 | 3.756 | 3.756 | 1.578 | 1.578 | 1.482 | 1.482 | 0.846 | 0.846 |
| Selling & Marketing Expenses
| 0.688 | 0.784 | 0.784 | 0.784 | 0.542 | 0.542 | 0.434 | 0.434 | 0.582 | 0.582 | 0.177 | 0.177 | 0.114 | 0.114 | 0.084 | 0.084 |
| SG&A
| 9.687 | 4.472 | 11.741 | 4.472 | 10.794 | 3.807 | 9.509 | 3.065 | 4.672 | 4.672 | 1.916 | 1.916 | 1.777 | 1.777 | 0.929 | 0.929 |
| Other Expenses
| -17.22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 15.89 | 5.26 | 19.379 | 5.56 | 17.717 | 5.191 | 15.724 | 4.582 | 6.147 | 6.147 | 2.888 | 2.888 | 2.572 | 2.572 | 1.545 | 1.545 |
| Operating Income
| -16.287 | -8.36 | -19.708 | -9.39 | -18.109 | -8.462 | -16.067 | -7.552 | -9.353 | -9.353 | -4.912 | -4.912 | -4.417 | -4.417 | -3.34 | -3.34 |
| Operating Income Ratio
| 82.258 | 39.065 | -42.474 | -20.237 | -30.564 | -14.282 | -33.369 | -15.684 | -23.009 | -23.009 | -16.765 | -16.765 | -14.997 | -14.997 | -31.659 | -31.659 |
| Total Other Income Expenses Net
| -0.55 | -0.072 | 0.471 | -0.229 | 0.531 | -0.327 | 0.107 | -0.428 | -1.392 | -1.392 | -1.466 | -1.466 | -1.193 | -1.193 | -1.048 | -1.048 |
| Income Before Tax
| -16.837 | -8.432 | -19.237 | -9.619 | -17.578 | -8.789 | -15.96 | -7.98 | -10.745 | -10.745 | -6.378 | -6.378 | -5.609 | -5.609 | -4.388 | -4.388 |
| Income Before Tax Ratio
| 85.035 | 39.4 | -41.459 | -20.73 | -29.668 | -14.834 | -33.146 | -16.573 | -26.433 | -26.433 | -21.766 | -21.766 | -19.046 | -19.046 | -41.592 | -41.592 |
| Income Tax Expense
| 0.062 | 0.028 | 0.045 | 0.023 | -0.801 | 0.401 | 0.035 | 0.018 | 0.027 | 0.027 | 0.008 | 0.008 | 0.004 | 0.004 | 0.014 | 0.014 |
| Net Income
| -16.899 | -8.459 | -19.282 | -9.641 | -16.777 | -8.389 | -15.995 | -7.998 | -10.772 | -10.772 | -6.386 | -6.386 | -5.605 | -5.605 | -4.402 | -4.402 |
| Net Income Ratio
| 85.348 | 39.528 | -41.556 | -20.778 | -28.316 | -14.158 | -33.219 | -16.61 | -26.498 | -26.498 | -21.794 | -21.794 | -19.032 | -19.032 | -41.725 | -41.725 |
| EPS
| -0.56 | -0.28 | -0.64 | -0.32 | -0.56 | -0.28 | -0.53 | -0.27 | -0.73 | -0.73 | -1.62 | -1.62 | -1.48 | -1.48 | -1.29 | -1.29 |
| EPS Diluted
| -0.56 | -0.28 | -0.64 | -0.32 | -0.56 | -0.28 | -0.53 | -0.26 | -0.72 | -0.72 | -1.62 | -1.62 | -1.48 | -1.48 | -1.29 | -1.29 |
| EBITDA
| -15.89 | -8.195 | -19.379 | -9.226 | -17.717 | -8.378 | -15.724 | -7.381 | -9.34 | -9.34 | -4.85 | -4.85 | -4.408 | -4.408 | -3.279 | -3.279 |
| EBITDA Ratio
| 80.253 | 38.297 | -41.765 | -19.883 | -29.902 | -14.14 | -32.656 | -15.328 | -22.977 | -22.977 | -16.553 | -16.553 | -14.966 | -14.966 | -31.076 | -31.076 |